University Of Notre Dame Du Lac Igm Biosciences, Inc. Transaction History

University Of Notre Dame Du Lac

  • $66.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$51.3 - $75.21 $1.3 Million - $1.91 Million
-25,394 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$31.51 - $73.75 $319,322 - $747,382
-10,134 Reduced 28.52%
25,394 $1.43 Million
Q4 2019

Feb 14, 2020
BUY
$17.25 - $49.51 $612,858 - $1.76 Million
35,528 New
35,528 $1.36 Million

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $258M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email